KORU Posts Second Straight Profitable Quarter, Lifts Margin and Cash Guidance
KRMD is trading near its 52-week low of $2.86 (10% above the low).
Summary
KORU delivered Q3 revenue of $11.6 million, up 11% year over year, with gross margin jumping to 65.2% from 60.2% on lower manufacturing costs, favorable geographic mix and tariff rebates. Net income swung to $0.2 million from a $0.8 million loss a year ago, and adjusted EBITDA rose to $1.3 million from $0.1 million — the second consecutive quarter of positive net income and adjusted EBITDA. Management narrowed full-year 2026 revenue guidance to $48.0-$48.5 million (17-18% growth) from $47.5-$48.5 million, raised gross margin guidance to 63-64% from 62-64%, and lifted the year-end cash target to above $8.0 million from above $7.5 million. Growth decelerated as expected on the European non-tender market launch, but the CEO expects reacceleration in Q4; the company also signed two new distribution deals in Europe and Africa. Cash stood at $7.4 million after $0.9 million of usage in the quarter, so the raised cash target implies a strong Q4 finish.
At the time of this announcement, KRMD was trading at $3.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $145.9M. The 52-week trading range was $2.86 to $6.61. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.